Silver Triflate-Palladium Chloride Cooperative Catalysis in a Tandem Reaction
113.7, 111.7, 97.8, 55.4; HR-MS (ACPI): m/z=275.1185,
calcd. for C18H15N2O+ [M+H+]: 275.1179.
CDCl3): d=161.9 (d, JC,F =245.7 Hz), 140.7, 138.4, 130.8 (d,
C,F =9.1 Hz), 125.6 (d, JC,F =8.9 Hz), 120.2, 115.2 (d, JC,F
J
=
23.8 Hz), 111.2 (d, JC,F =21.6 Hz), 108.7, 97.4, 30.7, 28.9,
22.6, 14.0; HR-MS (ACPI): m/z=243.1296, calcd. for
5-(4-Chlorophenyl)pyrazolo
G
(3k):
1H NMR (400 MHz, CDCl3): d=8.12 (d, J=6.8 Hz, 1H),
8.00 (d, J=2.0 Hz, 1H), 7.85 (d, J=8.0 Hz, 2H), 7.75–7.73
(m, 1H), 7.60–7.55 (m, 2H), 7.51 (d, J=8.0 Hz, 2H), 7.09
(d, J=2.0 Hz, 1H), 7.03 (s, 1H); 13C NMR (100 MHz,
CDCl3): d=140.9, 139.4, 137.3, 135.3, 132.2, 130.8, 129.0,
128.7, 128.1, 127.6, 127.2, 124.2, 123.6, 112.7, 98.0; HR-MS
(ACPI): m/z=279.0679, calcd. for C17H12N2Cl+ [M+H+]:
279.0684.
+
C15H16FN2 [M+H+]: 243.1292.
5-Cyclopropyl-8-methoxypyrazoloACTHUNTGRNEUNG[5,1-a]isoquinoline (3r):
1H NMR (400 MHz, CDCl3): d=8.01 (d, J=2.0 Hz, 1H),
7.96 (d, J=8.8 Hz, 1H), 7.10 (d, J=8.8 Hz, 1H), 7.02 (d, J=
1.6 Hz, 1H), 6.92 (d, J=2.0 Hz, 1H), 6.58 (s, 1H), 3.89 (s,
3H), 2.73–2.66 (m, 1H), 1.22–1.17 (m, 2H), 0.94–0.90 (m,
2H); 13C NMR (100 MHz, CDCl3): d=159.2, 141.3, 140.8,
138.9, 130.8, 125.0, 117.6, 116.4, 107.5, 106.5, 96.6, 55.4, 11.4,
7.1; HR-MS (ACPI): m/z=239.1206, calcd. for C15H15N2O+
[M+H+]: 239.1179.
5-CyclopropylpyrazoloACHTNUTGRNEUNG
[5,1-a]isoquinoline (3l): 1H NMR
(400 MHz, CDCl3): d=8.06 (d, J=2.0 Hz, 2H), 7.62 (d, J=
2.8 Hz, 1H), 7.50–7.47 (m, 2H), 7.05 (d, J=1.6 Hz, 1H),
6.65 (m, 1H), 2.73–2.66 (m, 1H), 1.23 À1.18 (m, 2H), 0.95–
0.91 (m, 2H); 13C NMR (100 MHz, CDCl3): d=140.7, 138.8,
129.1, 127.7, 126.6, 126.5, 123.4, 106.9, 97.8, 11.5, 7.0; HR-
6-Phenyl-9,10,11,12-tetrahydroindazoloACTHNUTRGNEUGN[3,2-a]isoquinoline
(3s):[5c] 1H NMR (400 MHz, CDCl3): d=8.18 (d, J=7.6 Hz,
1H), 7.91 (d, J=6.8 Hz, 2H), 7.71 (d, J=7.6 Hz, 1H), 7.54–
7.48 (m, 5H), 6.92 (s, 1H), 3.15 (t, J=6.0 Hz, 2H), 2.94 (d,
J=6.0 Hz, 2H), 1.98–1.94 (m, 4H); 13C NMR (100 MHz,
CDCl3): d=151.1, 138.5, 134.8, 134.3, 129.6, 129.4, 129.2,
128.3, 126.9, 126.8, 125.4, 123.3, 111.5, 109.9, 24.3, 23.6, 23.1,
23.0.
MS (ACPI): m/z=209.1080, calcd. for C14H13N2 [M+H+]:
+
209.1073.
5-Cyclopropyl-9-methylpyrazoloACTHUNTGRNEUNG[5,1-a]isoquinoline (3m):
1H NMR (400 MHz, CDCl3): d=8.04 (d, J=2.0 Hz, 1H),
7.85 (s, 1H), 7.51 (d, J=8.0 Hz, 1H), 7.31–7.29 (m, 1H),
7.02 (d, J=2.0 Hz, 1H), 6.62 (s, 1H), 2.71–2.64 (m, 1H),
2.51 (s, 3H), 1.21–1.16 (m, 2H), 0.93–0.89 (m, 2H);
13C NMR (100 MHz, CDCl3): d=140.5, 139.9, 138.7, 136.6,
129.3, 126.9, 126.4, 123.4, 123.2, 106.8, 97.6, 21.7, 11.4, 6.9;
1,2-Dimethyl-5-phenylpyrazolo
[5,1-a]isoquinoline
(3t):
+
HR-MS (ACPI): m/z=223.1255, calcd. for C15H15N2 [M+
H+]: 223.1230.
+
10.8; HR-MS (ACPI): m/z=273.1394, calcd. for C19H17N2
5-Cyclopropyl-9-fluoropyrazolo
(3n):
[M+H+]: 273.1386.
1H NMR (400 MHz, CDCl3): d=8.04 (d, J=2.4 Hz, 1H),
7.66 (dd, J=9.2 Hz, 1H), 7.58 (dd, J=8.8 Hz, 1H), 7.20 (t,
J=8.8 Hz, 1H), 6.98 (d, J=2.0 Hz, 1H), 6.60 (s, 1H), 2.69–
2.62 (m, 1H), 121–1.16 (m, 2H), 0.92–0.87 (m, 2H);
13C NMR (100 MHz, CDCl3): d=161.1(d, JC,F=245.4 Hz),
140.7, 140.1, 138.1, 128.7 (d, JC,F =8.6 Hz), 125.7, 124.5 (d,
2-Ethyl-5-phenylpyrazolo
N
(3t’):
J
C,F =9.3 Hz), 116.4 (d, JC,F =23.5 Hz), 108.6 (d, JC,F =
22.7 Hz), 106.3, 98.3, 11.3, 6.9; HR-MS (ACPI); m/z=
273.1375, calcd. for C19H17N2 [M+H+]: 273.1386.
+
227.0997, calcd. for C14H12FN2 [M+H+]: 227.0979.
5-Phenylbenzo[h]pyrazolo
G
(3o):
1H NMR (400 MHz, CDCl3): d=8.99 (d, J=8.4 Hz, 1H),
8.20 (d, J=2.0 Hz, 1H), 8.00 (d, J=8.00 Hz, 1H), 7.97–7.92
(m, 3H), 7.80 (t, J=8.0 Hz, 1H), 7.74 (d, J=8.4 Hz, 1H),
7.67 (t, J=7.6 Hz, 1H), 7.63 (d, J=2.2 Hz, 1H), 7.60–7.52
(m, 3H), 7.23 (s, 1H); 13C NMR (100 MHz, CDCl3): d=
141.7, 140.5, 139.9, 139.2, 138.7, 138.3, 136.6, 134.1, 132.9,
129.5, 129.4, 129.3, 129.2, 129.1, 129.0, 128.5, 127.5, 126.9,
126.4, 126.3, 125.7, 124.9, 123.4, 123.2, 120.3, 113.5, 106.8,
101.2, 97.6; HR-MS (ACPI): m/z=295.1242, calcd. for
Acknowledgements
Financial support from the National Natural Science Founda-
tion of China (Nos. 21032007, 21172038) is gratefully ac-
knowledged. We thank Dr. Jason Wong for English review.
+
C21H15N2 [M+H+]: 295.1230.
References
5-Cyclopropyl-8-fluoropyrazolo
[5,1-a]isoquinoline
(3p):
[1] For selected recent reviews on cooperative catalysts, see:
a) A. Ajamian, J. L. Gleason, Angew. Chem. 2004, 116,
3842–3848; Angew. Chem. Int. Ed. 2004, 43, 3754–3760;
b) J. M. Lee, Y. Na, H. Han, S. Chang, Chem. Soc. Rev.
2004, 33, 302–312; c) J. C. Wasilke, O. S. J. Brey, R. T.
Baker, G. C. Bazan, Chem. Rev. 2005, 105, 1001–1020;
d) D. Enders, C. Grondal, M. R. Huttl, Angew. Chem.
2007, 119, 1590–1601; Angew. Chem. Int. Ed. 2007, 46,
1570–1581; e) C. J. Chapman, C. G. Frost, Synthesis 2007,
1–21; f) A. M. Walji, D. W. C. MacMillan, Synlett 2007,
1477–1489; g) C. Wang, Z. Xi, Chem. Soc. Rev. 2007, 36,
1395–1406; h) Z. Shao, H. Zhang, Chem. Soc. Rev. 2009,
(d, JC,F =9.1 Hz), 115.2 (d, JC,F =23.8 Hz), 111.3 (d, JC,F
=
21.6 Hz), 106.03, 106.00, 97.5, 11.4, 7.2; HR-MS (ACPI):
+
m/z=227.1007, calcd. For C14H12FN2 [M+H+]: 227.0979.
5-n-Butyl-8-fluoropyrazolo
1H NMR (400 MHz, CDCl3): d=8.03–7.99 (m, 2H), 7.28 (d,
J=9.6 Hz, 1H), 7.21 (t, J=8.4 Hz, 1H), 6.95(s, 1H), 6.73 (s,
A
(3q):
AHCTUNGTRENNUNG
1H), 3.18–3.14 (m, 2H), 1.90–1.82 (m, 2H), 1.56–1.47 (m,
2H), 1.02–0.99 (t, J=7.2 Hz, 3H); 13C NMR (100 MHz,
Adv. Synth. Catal. 0000, 000, 0 – 0
ꢁ 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
5
ÞÞ
These are not the final page numbers!